NASDAQ:EDAPEdap Tms Stock Price, Forecast & News

$2.72

+0.11 (+4.21 %)

(As of 06/5/2020 04:00 PM ET)

Add

Compare

Today's Range

$2.54

Now: $2.72▼

$2.80

50-Day Range

$2.11

MA: $2.30▼

$2.71

52-Week Range

$1.46

Now: $2.72▼

$5.39

Volume96,200 shs

Average Volume116,218 shs

Market Capitalization$78.87 million

P/E Ratio38.86

Dividend YieldN/A

Beta1.64

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. This division also leases equipment; sells consumables; and offers treatment related services and maintenance services. The UDS division develops, manufactures, markets, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. This division also leases lithotripters; sells disposables and spare parts; and provides maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is headquartered in Vaulx-en-Velin, France.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
Edap Tms has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $5.25, Edap Tms has a potential upside of 93.0% from its current price of $2.72.
Amount of Analyst Coverage
Edap Tms has only been the subject of 2 research reports in the past 90 days.

2.5 Community Rank

Outperform Votes
Edap Tms has received 327 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Edap Tms has received 321 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Edap Tms has received 50.46% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Edap Tms and other stocks. Vote “Outperform” if you believe EDAP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EDAP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Edap Tms does not currently pay a dividend.
Dividend Growth
Edap Tms does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Edap Tms insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 18.16% of the stock of Edap Tms is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Edap Tms are expected to grow in the coming year, from ($0.22) to $0.00 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Edap Tms is 38.86, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.38.
Price to Earnings Ratio vs. Sector
The P/E ratio of Edap Tms is 38.86, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.65.
Price to Book Value per Share Ratio
Edap Tms has a P/B Ratio of 2.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.33 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:EDAP

Previous Symbol

CUSIPN/A

CIK1041934

Webwww.edap-tms.com

Phone33-04-72-15-31-50

Debt

Debt-to-Equity Ratio0.06

Current Ratio2.41

Quick Ratio1.94

Price-To-Earnings

Trailing P/E Ratio38.86

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$50.23 million

Price / Sales1.57

Cash Flow$0.14 per share

Price / Cash Flow19.87

Book Value$1.06 per share

Price / Book2.57

Profitability

EPS (Most Recent Fiscal Year)$0.06

Net Income$1.69 million

Net Margins4.38%

Return on Equity20.15%

Return on Assets10.39%

Miscellaneous

Employees215

Outstanding Shares28,997,000

Market Cap$78.87 million

Next Earnings Date8/26/2020 (Estimated)

OptionableOptionable

Receive EDAP News and Ratings via Email

Sign-up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.

Edap Tms (NASDAQ:EDAP) Frequently Asked Questions

How has Edap Tms' stock been impacted by COVID-19 (Coronavirus)?

Edap Tms' stock was trading at $2.48 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EDAP shares have increased by 9.7% and is now trading at $2.72. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Edap Tms?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Edap Tms.

When is Edap Tms' next earnings date?

Edap Tms is scheduled to release its next quarterly earnings announcement on Wednesday, August 26th 2020. View our earnings forecast for Edap Tms.

How were Edap Tms' earnings last quarter?

Edap Tms SA (NASDAQ:EDAP) announced its quarterly earnings data on Monday, March, 30th. The medical equipment provider reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by $0.09. The medical equipment provider earned $13.35 million during the quarter, compared to analysts' expectations of $14.27 million. Edap Tms had a net margin of 4.38% and a return on equity of 20.15%. View Edap Tms' earnings history.

What price target have analysts set for EDAP?

2 Wall Street analysts have issued 12-month target prices for Edap Tms' stock. Their forecasts range from $5.00 to $5.50. On average, they anticipate Edap Tms' stock price to reach $5.25 in the next year. This suggests a possible upside of 93.0% from the stock's current price. View analysts' price targets for Edap Tms.

Has Edap Tms been receiving favorable news coverage?

Media coverage about EDAP stock has been trending positive on Friday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Edap Tms earned a news impact score of 2.7 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutEdap Tms.

Who are some of Edap Tms' key competitors?

Some companies that are related to Edap Tms include TransMedics Group (TMDX), Viewray (VRAY), Semler Scientific (SMLR), BioSig Technologies (BSGM), Cutera (CUTR), Fonar (FONR), Soleno Therapeutics (SLNO), Fc Global Realty (FCRE), electroCore (ECOR), IRIDEX (IRIX), Reshape Lifesciences (RSLS), Helius Medical Technologies (HSDT), Precision Optics (PEYE), Second Sight Medical Products (EYES) and CHF Solutions (CHFS). View all competitors.

What other stocks do shareholders of Edap Tms own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Edap Tms investors own include Energous (WATT), Weatherford International (WFT), CTI BioPharma (CTIC), PETROLEO BRASIL/ADR (PBR), Kandi Technologies Group (KNDI), Misonix (MSON), Achillion Pharmaceuticals (ACHN), Advanced Micro Devices (AMD), Destination Maternity (DESTQ) and Pacific Drilling (PACDQ).

Who are Edap Tms' key executives?

Edap Tms' management team includes the following people:

Mr. Marc Oczachowski, CEO & Exec. Director (Age 49)
Mr. Franois Dietsch, Chief Financial Officer (Age 43)
Ms. Blandine Confort, Investor Relations Officer and Sec.

What is Edap Tms' stock symbol?

Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."

Who are Edap Tms' major shareholders?

Edap Tms' stock is owned by many different retail and institutional investors. Top institutional shareholders include Morgan Stanley (1.90%), Wellington Management Group LLP (0.93%), Cahill Financial Advisors Inc. (0.47%), Fosun International Ltd (0.33%), Personal CFO Solutions LLC (0.16%) and Acadian Asset Management LLC (0.15%).

Which major investors are selling Edap Tms stock?

EDAP stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Fosun International Ltd, and New York State Common Retirement Fund.

Which major investors are buying Edap Tms stock?

EDAP stock was bought by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Cahill Financial Advisors Inc., Morgan Stanley, and Personal CFO Solutions LLC.

How do I buy shares of Edap Tms?

Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Edap Tms' stock price today?

One share of EDAP stock can currently be purchased for approximately $2.72.

How big of a company is Edap Tms?

Edap Tms has a market capitalization of $78.87 million and generates $50.23 million in revenue each year. The medical equipment provider earns $1.69 million in net income (profit) each year or $0.06 on an earnings per share basis. Edap Tms employs 215 workers across the globe.

What is Edap Tms' official website?

The official website for Edap Tms is www.edap-tms.com.

How can I contact Edap Tms?

Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff